Catalyses the transfer of the acetyl group from 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the sn-2 position of lyso-glycerophospholipids containing ethanolamine, choline, serine, inositol or phosphate groups at the sn-3 position as well as to sphingosine and long-chain fatty alcohols. The organyl group can be alkyl, acyl or alk-1-enyl (sometimes also collectively referred to as ’radyl’).
The enzyme appears in viruses and cellular organisms
Catalyses the transfer of the acetyl group from 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) to the sn-2 position of lyso-glycerophospholipids containing ethanolamine, choline, serine, inositol or phosphate groups at the sn-3 position as well as to sphingosine and long-chain fatty alcohols. The organyl group can be alkyl, acyl or alk-1-enyl (sometimes also collectively referred to as 'radyl').
Substrates: ATP regulates the activity of the enzyme by reversible activation and inactivation via the phosphorylation and dephosphorylation cycle Products: -
Substrates: the enzyme may participate in the biosynthesis of ethanolamine plasmalogen and acyl analogs of platelet-activating factor, in vivo, finetuning of platelet-activating factor biological responses and cross-talk between de novo and remodeling pathways of platelet biosynthesis Products: -
Substrates: the enzyme transfers short-chain fatty acids from platelet-activating factor PAF and its close ether- and ester-linked analogues to ether/ester-linked lysophospholipids, enzyme activity distribution within different LDL-subfactions, overview Products: -
Substrates: PAF-AH II is a multifunctional enzyme with three catalytic activities: lysophospholipid transacetylase, sphingosine transacetylase and acetylhydrolase Products: -
Substrates: ATP regulates the activity of the enzyme by reversible activation and inactivation via the phosphorylation and dephosphorylation cycle Products: -
Substrates: the enzyme may participate in the biosynthesis of ethanolamine plasmalogen and acyl analogs of platelet-activating factor, in vivo, finetuning of platelet-activating factor biological responses and cross-talk between de novo and remodeling pathways of platelet biosynthesis Products: -
Substrates: the enzyme transfers short-chain fatty acids from platelet-activating factor PAF and its close ether- and ester-linked analogues to ether/ester-linked lysophospholipids, enzyme activity distribution within different LDL-subfactions, overview Products: -
lyso- platelet-activating factor accumulation and an increase in platelet-activating factor bioactivity is observed in the aorta of some patients. In atherogenic aortas, an imbalance between PAF-AH and transacetylase activity, as well as lyso-platelet-activating factor accumulation, may lead to unregulated platelet-activating factor formation and to progression of atherosclerosis
the enzyme participates in regulating platelet activating-factor levels in monocytes and macrophages. The enzyme protects cells against oxidative stress and attenuates mast cell activation
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
EXPRESSION
ORGANISM
UNIPROT
LITERATURE
enzyme activity is increased in the supplement group (receive Aloe gel, grape juice, Polygonum cuspidatum extract as well as vitamins) at 4 and 8 weeks compared with baseline levels
the amount of enzyme alpha1 subunit protein and mRNA is significantly reduced in 3T3-L1 differentiation, while the amount of the enzyme alpha2 subunit is not changed
the enzyme is an independent positive prognostic factor for overall survival in ovarian carcinoma and correlates with the Wnt signaling proteins pGSK3beta and beta-catenin
A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acetyl analogs of platelet-activating factor (PAF) with PAF as the actetate donor in HL-60 cells
The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells
Nakamura, Y.; Kihara-Negishi, F.; Tanigawa, K.; Kiriya, M.; Kadowaki, Y.; Imagawa, H.; Nakanishi, H.; Watanabe, S.; Maruyama, K.; Karasawa, K.
A complex of type I platelet-activating factor acetylhydrolase (PAF-AH) catalytic subunits switches from alpha1/alpha2 heterodimer to alpha2/alpha2 homodimer during adipocyte differentiation of 3T3-L1 cells
Platelet-activating factor acetylhydrolase expression in BRCA1 mutant ovarian cancer as a protective factor and potential negative regulator of the Wnt signaling pathway